GenBioPro, Inc. v. Raynes et al

  1. February 08, 2024

    Drugmaker Challenges W.Va. Abortion Ban In 4th Circ.

    GenBioPro, which makes generic mifepristone, a drug used to end early pregnancies, is urging the Fourth Circuit to reverse a lower court's finding that West Virginia's ban on most abortions is not an unconstitutional obstacle to federal law. 

  2. August 24, 2023

    W.Va. AG Knocks Out Bulk Of Challenge To Abortion Pill Ban

    A West Virginia federal judge on Thursday axed GenBioPro's challenge to a state law severely restricting access to medication abortions, saying the U.S. Supreme Court has repeatedly affirmed that morality-based product bans are not intrinsically unconstitutional, but allowed the pharmaceutical company's claim over telemedicine prescribing restrictions to proceed.

  3. June 22, 2023

    Abortion Litigation To Watch As Dobbs Decision Turns 1

    The U.S. Supreme Court's elimination of the constitutional right to abortion hit like an earthquake last summer, uprooting long-standing reproductive rights, triggering state laws curbing abortion access and flooding courts with litigation. A year later, legal battles promise further shake-ups to the abortion landscape.

  4. May 03, 2023

    W. Va. Abortion Drug Law Fight Can Continue, Judge Rules

    A West Virginia federal judge shot down requests to throw out GenBioPro's lawsuit against a West Virginia law that limits the use of a drug used in medication abortions, finding that the adequate standing requirements were met.

  5. January 25, 2023

    Abortion Drug Restrictions Draw Challenges In W.Va., NC

    Drugmaker GenBioPro has launched a lawsuit against a West Virginia law that limits the use of a drug used in medication abortions, the same day a legal attack was directed at a similar North Carolina law.